Print Friendly, PDF & Email

Saturday 8th September 2018 [Pre-ASM Courses]

0730 Pre-ASM Course Registration | Level 1
  Nephrology and Transplantation Update Course | MR C4.8, Level 4 KidGen 2018 Renal Genetics Symposium | MR C4.9, Level 4
0800-1815

The 2018 ANZSN Nephrology and Transplantation Update Course will be held at the International Convention Centre Saturday 8th and Sunday 9th September.


Click here for the full program

KidGen Renal Genetics Symposium 2018
Renal Genomics – Translating the Potential


Click here for the full program

1830-2200 Nephrology and Transplantation Update Course Dinner | Sydney Harbour Cruise
Full Nephrology and Transplantation Update Course delegates are inclusive, additional tickets can be purchased for guests and day delegates for $100.  Bookings essential!


Sunday 9th September 2018 [Pre-ASM Courses]

0730 Pre-ASM Course Registration | Level 1
0930-1630 ANZSN Council Meeting (closed session) | VIP Boardroom, Level 1
  Nephrology and Transplantation Update Course | MR C4.8 KidGen 2018 Renal Genetics Symposium | MR C4.9 Patient Education Session | MR C4.10 Renal Dietitians Update Day | MR C3.4 Meetings | MR C3.1
0800-1640

ANZSN Nephrology and Transplantation Update Course continues


Click here for the full program

KidGen Renal Genetics Symposium 2018
Renal Genomics – Translating the Potential


Click here for the full program

1000-1300

Coordinated by BEAT-CKD in partnership with Kidney Health Australia and sponsored by ANZSN

Click here for the full program


Closed session – click here to book

 

0800-1600

This pre-congress meeting brings together Renal Dietitians from across Australia and New Zealand and South-East Asia. It provides an opportunity for Dietitians to:

  • Share best practice in the area of nutrition for kidney disease
  • Find out about the latest research and trends
  • Network with colleagues

Click here for full program

1000-1300: SPEC


1300-1530: CPAC


1530-1730: RAC

 

1020-1220

COMBINED COURSES – ANZSN Nephrology and Transplantation Update Course & KidGen 2018 Renal Genetics Symposium


Participants booked for either course may attend this combined session in Meeting Room C4.8

1220 Update Course / Kidgen Lunch | Level 4 Foyer
Advanced Trainees Workshop | C4.8
1310-1700 ANZSN Nephrology and Transplantation Update Course continues KidGen 2018 Renal Genetics Symposium continues

1400

PKD Public Seminar


Click here for more information

1730-1900

Advanced Trainee Research Meeting: Research opportunities during and beyond nephrology training


Click here for more information

 1900 President’s Dinner (by invitation only) | glass brasserie, Hilton Sydney

ASM PROGRAM

10TH – 12TH SEPTEMBER 2018

Monday 10th September 2018 – ANZSN ASM 2018

0700-0800 Editorial Board Meeting | VIP Boardroom, Level 1
0700 Registration Desk & Speakers Preparation Room Open | Ground Level
  Opening Plenary 1 | Cockle Bay, Level 3
Chairs: Jonathan Craig & Germaine Wong
0800-0810 Welcome to Delegates | Martin Gallagher, 2018 ASM Chair
Welcome to Country
| Uncle Chicka Madden
0810-0905 Keynote Speaker: Minnie Sarwal
PRECISION TRANSPLANT MEDICINE: DAWN OF A NEW AGE


Minnie Sarwal is Professor of Surgery, with joint appointments in Medicine and Pediatrics, Director of Precision Transplant Medicine at the University of California San Francisco (UCSF), and additional positions as Adjunct Professor, Haas School of Business, University of California Berkeley, and Adjunct Professor at the Faculty of Health Sciences, Odense, Sweden.  Full biography.

0910-1000 Keynote Speaker: David Kavanagh
ATYPICAL HAEMOLYTIC URAEMIC SYNDROME – GENETICS, THERAPEUTICS AND CLINICAL OUTCOMES – THE UK EXPERIENCE


David Kavanagh is the Professor of Complement Therapeutics at the National Renal Complement Therapeutics Centre (NRCTC). He is the clinical lead for the adult aHUS service and head of aHUS diagnostics service. His University research group investigates the role of complement in renal and retinal diseases and is fully integrated with the NRCTC to provide rapid translational benefits to patients. Full biography.

1000-1030 Morning Tea | Exhibition Area, Parkside Ballroom, Level 2
1000-1030 PHOSPHATE Trial Meeting (bookings essential – click here) , E5.2, Level 5
  Young Investigator Award Prize Orals | Cockle Bay, Level 3
Chairs: Frank Ierino & Sharon Ricardo
1030-1045 A CRUCIAL ROLE FOR INTERLEUKIN-18 IN THE DEVELOPMENT OF RENAL INFLAMMATION AND ELEVATED BLOOD PRESSURE IN 1 KIDNEY/DOCA/SALT-INDUCED HYPERTENSION
Jordyn Thomas
1045-1100 ANNUAL SCREENING VERSUS NO SCREENING FOR ASYMPTOMATIC CORONARY ARTERY DISEASE IN WAIT-LISTED KIDNEY TRANSPLANT CANDIDATES: A MODELLED COST-EFFECTIVENESS ANALYSIS
Tracey Ying
1100-1115 TLR AGONISTS EXCERBATE ACUTE KIDNEY INJURY MIMICKING AHUS IN A CFH MUTANT MOUSE WITH A KNOWN HUMAN MUTATION
Victor Shen
1115-1130 IMPACT OF EXTENDED HOURS DIALYSIS ON UTILITY-BASED QUALITY OF LIFE: RESULTS FROM THE ACTIVE DIALYSIS TRIAL
Brendan Smyth
1130-1145 INABILITY TO REGULATE FATTY ACID OXIDATION OR GLYCOLYSIS INCREASES RENAL FIBROSIS
Mardiana Lee
1145-1200 ASSOCIATIONS OF COGNITIVE FUNCTION AND EDUCATIONAL LEVEL WITH ALL-CAUSE MORTALITY IN ADULTS ON HAEMODIALYSIS: THE COGNITIVE-HD COHORT STUDY
Anita Van Zwieten
1200-1215 KCA3.1 MEDIATED DYSREGULATION OF MITOCHONDRIAL QUALITY CONTROL IN DIABETIC NEPHROPATHY
Chunling Huang
1215-1230 DEVELOPING CONSENSUS-BASED OUTCOME DOMAINS FOR TRIALS IN PERITONEAL DIALYSIS: AN INTERNATIONAL DELPHI SURVEY
Karine Manera
1230-1330 Lunch | Exhibition Area, Parkside Ballroom, Level 2
1330-1500 Concurrent Session 1 | Level 3
Seminar 1: Clinical Science | Cockle Bay
Chairs: Muh Geot Wong & Yvonne Shen
Mini Orals | MR C3.2
Transplantation
Chairs: Jagadish Jamboti & 
Leyla Aouad
Mini Orals | MR C3.4+ C3.5
Experimental Immunology / Glomerulonephritis
Chairs: Poh-Yi Gan & Gopala Rangan
Mini Orals | MR C3.6
Epidemiology & Public Health
Chairs: Phil Clayton & Sradha Kotwal
PERSONALISED DIALYSIS
Angela Wang


Angela Yee Moon Wang, MD, PhD, FRCP, is a Clinician Scientist working at the Queen Mary Hospital, University of Hong Kong, Hong Kong and was graduated from the University of New South Wales, Australia. Full biography.

KIDNEY TRANSPLANT OUTCOMES ARE RELATED TO MYCOPHENOLIC ACID EXPOSURE AT 5 WEEKS AND 3 MONTHS POST TRANSPLANT
Katherine Barraclough
TISSUE-RESIDENT MUCOSAL-ASSOCIATED INVARIANT T (MAIT) CELLS IN HUMAN RENAL FIBROSIS AND CHRONIC KIDNEY DISEASE (CKD)
Helen Healy
DIETARY PLANT AND ANIMAL PROTEIN INTAKE AND THE DECLINE IN ESTIMATED GLOMERULAR FILTRATION RATE AMONG ELDERLY WOMEN: A 10-YEAR LONGITUDINAL COHORT STUDY
Amelie Bernier-Jean
FOLLOW UP OF KIDNEY TRANSPLANT RECIPEINTS USING VIDEOCONFERENCING: A SINGLE CENTRE EXPERIENCE
Katherine Barraclough
DEFICIENCY OF MINERALOCORTICOID SIGNALING IN MACROPHAGES PROVIDES PROTECTION AGAINST KIDNEY AND CARDIAC INJURY IN HYPERTENSIVE DIABETIC MICE
Gregory Tesch
END-STAGE KIDNEY DISEASE FOLLOWING SURGICAL MANAGEMENT OF KIDNEY CANCER IN QUEENSLAND
Robert Ellis
CLINICAL AUDIT OF URINARY TRACT INFECTIONS IN RENAL TRANSPLANT PATIENTS AT THE ROYAL BRISBANE AND WOMEN’S HOSPITAL
Simon Olenski
COMBINED INHIBITION OF CCR2 AND ACE PROVIDES ADDED PROTECTION AGAINST PROGRESSION OF DIABETIC NEPHROPATHY IN NOS3 DEFICIENT MICE
Gregory Tesch
CANCER MORTALITY IN PEOPLE ON DIALYSIS IN AUSTRALIA AND NEW ZEALAND: A NATIONAL COHORT STUDY FROM 1980 TO 2013
Brenda Rosales
FACTORS ASSOCIATED WITH LOSS TO FOLLOW-UP OF LIVING KIDNEY DONORS (LKD) AND EVALUATION OF CHANGES IN BODY WEIGHT AFTER DONATION
Anoushka Krishnan
LOW DOSE INTERLEUKIN-2 THERAPY MODULATES AUTOIMMUNITY AND RENAL INJURY IN EXPERIMENTAL ANTI-MYELOPEROXIDASE GLOMERULONEPHRITIS
Jonathan Dick
CHRONIC KIDNEY DISEASE IS NOT CHARACTERISED SOLELY BY THOSE STARTING RENAL REPLACEMENT THERAPY
Wendy Hoy
IgA NEPHROPATHY – 50 YEARS AND WHAT HAVE WE LEARNED?
Sydney Tang


Sydney Tang graduated from the University of Hong Kong and has obtained MD and PhD degrees at the University of Hong Kong. He has undergone training in basic science research in nephrology at Guy’s Hospital, King’s College London, and Seattle Children’s Hospital, University of Washington. Full biography.

EXPOSURE TO A FUNCTIONING KIDNEY TRANSPLANT AND CANCER RISKS
Eric Au
ROLE OF JNK SIGNALLING IN PODOCYTE DAMAGE AND PROTEINURIA IN EXPERIMENTAL GLOMERLULAR DISEASE
David Nikolic-Paterson
PROFILE OF PATIENTS IN A RENAL SPECIALTY PRACTICE IN METROPOLITAN SYDNEY, UTILISING AUDIT4: ARE THEY DIFFERENT?
Wendy Hoy
OPTIMISING LIVING KIDNEY DONOR FOLLOW UP
Ellie Cash
VALIDATION OF A WEB-BASED CLINICAL DECISION SUPPORT SYSTEM TO PREDICT END-STAGE KIDNEY DISEASE IN AN AUSTRALIAN IMMUNOGLOBIN A NEPHROPATHY COHORT
Andrew Mallett
ASSESSING BASELINE MEDICATION USE IN CHRONIC KIDNEY DISEASE: AN ANALYSIS OF THE SHARP-ER STUDY
Min Jun
SYSTEMATIC REVIEW OF RISK INDICES USED IN PANCREAS TRANSPLANTATION
Jonathan Ling
RECOGNISING THE SUBTLE CLINCOPATHOLOGICAL FEATURES OF C3GN COMPARED TO OTHER COMPLEMENT MEDIATED GLOMERULOPATHY IN AN AUSTRALIAN TERTIARY INSTITUTION
Prianka Puri
THE IMPACT ON HEALTH-RELATED QUALITY-OF-LIFE OF COMORBID DIABETES AND CKD: A 12 YEAR COMMUNITY COHORT STUDY
Melanie Wyld
INTERVENTIONS FOR THE PREVENTION OF SKIN CANCERS IN SOLID ORGAN TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
Laura James
HISTOPATHOLOGICAL CHARACTERISTICS OF GLOMERULONEPHRITIS PATIENTS UNDERWENT KIDNEY BIOPSY IN Dr. KARIADI HOSPITAL IN SEMARANG, CENTRAL JAVA, INDONESIA
Selamet Hidayat
A RETROSPECTIVE CASE-CONTROL STUDY EXPLORING RISK FACTORS FOR LOSS OF KIDNEY TRANSPLANT FUNCTION OR DEATH AMONG INDIGENOUS TRANSPLANT RECIPIENTS
Namrata Khanal
HIV NEPHROPATHY –DIAGNOSIS AND MANAGEMENT
Adrian Liew


Dr Adrian Liew is a Senior Consultant and Chief of Nephrology at the Department of Renal Medicine, Tan Tock Seng Hospital in Singapore. Full biography.

COMMUNITY PREFERENCES FOR THE ALLOCATION OF KIDNEYS FROM DECEASED DONORS: A NATIONAL BEST-WORST SCALING SURVEY
Martin Howell
MICRO PROTEOMIC PROFILING IN THE DIAGNOSIS OF KIDNEY DISEASE
Arti Raghubar
HOUSING PROVISION AND HEALTH OUTCOMES AMONG NORTHERN TERRITORY HAEMODIALYSIS PATIENTS: THE DIALYSIS MODELS OF CARE PARTNERSHIP
Paul Lawton
POST-TRANSPLANT ACUTE KIDNEY INJURY AFFECTS LONG-TERM GRAFT FUNCTION
Madhu Prita Prakash
IDIOPATHIC MEMBANOUS NEPHROPATHY IN SOUTHERN TASMANIA
Stephanie Kuo
DIETARY INFLAMMATORY INDEX AND THE AGEING KIDNEY IN OLDER WOMEN: A 10-YEAR PROSPECTIVE COHORT STUDY
Nicola Bondonno
PROTEASE-ACTIVATED RECEPTORS AS A POTENTIAL THERAPEUTIC TARGET IN CIRCULATING FACTOR TYPE NEPHROTIC SYNDROME
Mahnoor Bakhtiar
REMOTENESS AND DIALYSIS QUALITY OF CARE
Dev Jegatheesan
A COMPARISON OF THE EQ-5D-3L AND THE AQOL-4D FOR ASSESSING HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH CHRONIC KIDNEY DISEASE
Charlotte McKercher
1500-1530 Afternoon Tea | Exhibition Area, Parkside Ballroom, Level 2
1500-1530 TEACH-PD Trial Meeting (bookings essential – click here) , E5.2, Level 5
1530-1700 Concurrent Session 2 | Level 3
  KHA Award | Cockle Bay
Chairs: Martin Gallagher & Shilpa Jesudason
Seminar 2: Basic Science | MR C3.2
Chairs: Steve Alexander & Karen Dwyer
Mini Orals | MR C3.4+C3.5
Haemodialysis
Chairs: Andrea Viecelli & Kamal Sud
Mini Orals | MR C3.6
Health Services Research
Chairs: Celine Foote
1530-1545 ASSOCIATION OF FRUIT AND VEGETABLE INTAKE WITH ALL-CAUSE MORTALITY IN HEMODIALYSIS PATIENTS (DIET-HD): A PROSPECTIVE COHORT STUDY
Valeria Saglimbene
TOWARDS TARGETED THERAPIES IN KIDNEY DISEASE
Anna Greka


Anna Greka, an institute member of the Broad Institute of MIT and Harvard, is a physician-scientist leading the translation of scientific discoveries from the laboratory to clinical trials. Full biography.

EXTENDING THE ANZDATA REGISTRY – UNDERSTANDING OUTPATIENT HEALTH SERVICE USE
Sradha Kotwal
MEDICAL NUTRITION THERAPY SLOWS DOWN TIME TO DIALYSIS IN PATIENTS ATTENDING A PRE-DIALYSIS CLINIC: AN OBSERVATIONAL COHORT STUDY
Stephanie Notaras
HYPOMAGNESEMIA IN HAEMODIALYSIS PATIENTS ON PROTON PUMP INHIBITORS
Viduranga Wijeratne
HEALTH-RELATED QUALITY OF LIFE IN PEOPLE OVER 75 YEARS OF AGE WITH END-STAGE KIDNEY DISEASE MANAGED WITH COMPREHENSIVE CONSERVATIVE CARE OR DIALYSIS
Karan Shah
1545-1600 MACHINE LEARNING PREDICTION FOR DE NOVO DONOR SPECIFIC ANTIBODIES (dnDSA), AMR AND GRAFT LOSS IN SIMULTANEOUS KIDNEY PANCREAS (SPK) TRANSPLANT RECIPIENTS
Ankit Sharma
PREVALENCE OF MALNUTRITION AS CLINICAL TARGET IN MAINTENANCE HAEMODIALYSIS, IS IT A GOOD INDICATOR?
Maria Chan
SHOULD WE BE MEASURING “WELLBEING” IN OLDER PEOPLE WITH END-STAGE KIDNEY DISEASE, RATHER THAN HEALTH-RELATED QUALITY OF LIFE? A PROSPECTIVE CROSS-SECTIONAL STUDY IN THE UK AND AUSTRALIA
Karan Shah
PNEUMOCOCCAL VACCINATION AWARENESS IN HEMODIALYSIS
Sibel Bek
COST-EFFECTIVENESS IN KIDNEY MEDICINE: IS CINACALCET SUPERIOR TO PARATHYROIDECTOMY?
Katharine Hegerty
1600-1615 COMPARATIVE COST EVALUATION OF DIALYSIS SERVICE MODELS IN REMOTE AND REGIONAL AUSTRALIA: DXMOC STUDY
Gillian Gorham
ANTIGEN SPECIFIC REGULATORY T CELLS TO TREAT AUTOIMMUNE GLOMERULONEPHRITIS
Joshua D. Ooi


Dr. Ooi is an Al and Val Rosentrauss Fellow at Monash University. He specializes in the identification of autoimmune T cell epitopes and understanding the basis of autoimmune susceptibilities. Full biography.

FACTORS ASSOCIATED WITH REGRESSION OF LEFT VENTRICULAR MASS INDEX IN THE ACTIVE DIALYSIS TRIAL
Brendan Smyth
INDIGENOUS PATIENT EXPERIENCES OF RETURNING TO COUNTRY: A QUALITATIVE EVALUATION OF THE COUNTRY HEALTH SA DIALYSIS TRUCK
Jessica Conway
THE QUALITY OF LIFE IMPROVEMENTS ASSOCIATED WITH EXTENDED HOURS DIALYSIS ARE CONSISTENT ACROSS SUBGROUPS
Brendan Smyth
SYMPTOM BURDEN AND EUROQOL EQ-5D-5L UTILITY-BASED QUALITY OF LIFE FOR AUSTRALIAN PATIENTS WITH END-STAGE KIDNEY DISEASE RECEIVING RENAL SUPPORTIVE CARE: PRELIMINARY RESULTS FROM A PROSPECTIVE STATEWIDE COHORT ANALYSIS
Rachael Morton
1615-1630 ALLOCATION OF LOW-RISK KIDNEYS: CAN WE OPTIMISE UTILISATION?
Philip Clayton
RELATIVE CONTRIBUTIONS TO MAJOR DIALYSIS RANDOMISED CONTROLLED TRIALS FROM TEN GLOBAL REGIONS
Brendan Smyth
PATIENT REPORTED OUTCOME MEASURES IN AUSTRALIAN AND NEW ZEALAND RENAL UNITS: AN ANZDATA SURVEY OF CURRENT PRACTICE
Rachael Morton
EXPERIENCES AND PERSPECTIVES OF PATIENTS ON HAEMODIALYSIS REGARDING THEIR DIETARY MANAGEMENT: AN INTERVIEW STUDY
Jessica Stevenson
EARLY EVALUATION OF AN INNOVATIVE PAEDIATRIC NEPHROLOGY SERVICE IN THE NORTHERN TERRITORY OF AUSTRALIA: A CARER’S AND PROVIDER’S PERSPECTIVE
Swasti Chaturvedi
1630-1645 LONGITUDINAL CHANGES IN BODY MASS INDEX AND THE COMPETING OUTCOMES OF DEATH AND TRANSPLANT IN PATIENTS UNDERGOING HEMODIALYSIS: A LATENT CLASS JOINT MODELLING APPROACH
Kevan Polkinghorne
CILIOPATHIES – LABORATORY MODELS TO CLINICAL PHENOTYPE
Philip Beales


Philip Beales is Professor of Medical and Medical Genetics at UCL in London, UK and an NIHR Senior Investigator. He is chair of the new UCL Institute for Precision Medicine and Director of the Centre for Translational Genomics (GOSGENE). Full biography.

CAUSE OF DEATH VARIES ACROSS AUSTRALIA, NEW ZEALAND AND MALAYSIA IN THOSE ON RENAL REPLACEMENT THERAPY – RESULTS FROM THE STUDY OF HEART AND RENAL PROTECTION-EXTENDED REVIEW (SHARP-ER)
Benjamin Talbot
CKD.QLD: PROFILE AND LONG-TERM OUTCOMES OF ABORIGINAL & TORRES STRAIT ISLANDER (A&TSI) PEOPLE WITH CHRONIC KIDNEY DISEASE (CKD) FROM DARLING DOWNS, QUEENSLAND
Sree Krishna Venuthurupalli
HIGH INTRA-INDIVIDUAL PTH VARIABILITY COMPLICATES USE OF PTH TO DRIVE CLINICAL PROTOCOLS FOR DOSING CALCIMIMETICS AND VITAMIN D IN HEMODIALYSIS PATIENTS
Antonia Harford
WHAT IS RENAL SUPPORTIVE CARE? RESULTS FROM A SURVEY OF CLINICIANS’ VIEWS AND EXPERIENCES IN AUSTRALIA AND NEW ZEALAND
Kathryn Ducharlet
1645-1700 AUSTRALIAN ESKD HOT SPOTS
Stephen McDonald
FOOD AS MEDICINE? PRELIMINARY RESULTS OF A PRAGMATIC CLINICAL TRIAL TO DETERMINE THE SAFETY AND EFFICACY OF USING NUTS TO IMPROVE BOWEL HEALTH IN HAEMODIALYSIS PATIENTS
Kelly Lambert
PHYSICIAN BURNOUT IN NEPHROLOGY
Viduranga Wijeratne
1700-1800 ANZSN Annual General Meeting | Cockle Bay, Level 3
All Members and interested Members welcome.  Click here to indicate your attendance.
1800-1930

KHA 50 year Celebration & ASM Welcome Reception 

Please join us as we celebrate 50 years of KHA! | Exhibition Area, Parkview Ballroom, Level 2

Welcome to the 2018 Annual Scientific Meeting! This is the first social opportunity to catch up with your interstate colleagues and sponsors and exhibitors of the Meeting.  The welcome reception also provides a great opportunity to meet delegates who are attending the ASM for the first time.

POSTER VIEWING SESSION:  During the Welcome Reception poster authors are invited to stand beside their poster and answer questions from delegates.


Tuesday 11th September 2018- ANZSN ASM 2018

0700 Registration Desk & Speakers Preparation Room Open | Ground Level
  Plenary 2 | Cockle Bay, Level 3
Chair: Carmel Hawley
0800-0850 AKTN Session
0850-0900 ROOM CHANGEOVER
0900-1000 Concurrent Session 3 | Level 3
Seminar 3: Clinical Science | Cockle Bay
Chairs: Richard Kitching & Carolyn Clark

Mini Orals | MR C3.2
Haemodialysis
Chairs: Susan Crail & Doris Chan
Mini Orals | MR C3.4+C3.5
Experimental Tubulointerstitial
Chairs: Bo Wang & Sonia Saad
Mini Orals | MR C3.6
General Nephrology
Chairs: Stella McGinn & Grant Luxton
PREGNANCY-INDUCED THROMBOTIC MICROANGIOPATHY – UNSCRAMBLING THE CLINICAL SPECTRUM OF aHUS, TTP, HELLP, PRE-ECLAMPSIA
David Kavanagh


David Kavanagh is the Professor of Complement Therapeutics at the National Renal Complement Therapeutics Centre (NRCTC). He is the clinical lead for the adult aHUS service and head of aHUS diagnostics service. His University research group investigates the role of complement in renal and retinal diseases and is fully integrated with the NRCTC to provide rapid translational benefits to patients. Full biography.

IMPROVING SYMPTOMS AMONG DIALYSIS PATIENTS THROUGH RENAL SUPPORTIVE CARE
Amanda Siriwardana
COMPARISON OF DIABETIC RENAL INJURY IN MALE AND FEMALE NOS3 DEFICIENT MICE
Lifang Tian
CD47 BLOCKADE MODULATES FIBROSIS IN CHRONIC KIDNEY INJURY
Natasha Rogers
HOW FAR DO PEOPLE TRAVEL TO DIALYSIS? TIME AND DISTANCE TRAVELLED FOR METROPOLITAN HAEMODIALYSIS PATIENTS
Stephen McDonald
β-CATENIN/FOXO AMELIORATES KIDNEY FIBROSIS
Padmashree Rao
CLINICAL OUTCOMES OF PARATHYROIDECTOMY IN CHRONIC KIDNEY DISEASE PATIENTS
Katharine Hegerty
THE CONTRIBUTION OF RESIDUAL KIDNEY FUNCTION TO SOLUTE CLEARANCE AND POTASSIUM HOMEOSTASIS IN HAEMODIALYSIS PATIENTS
Jessica Kong
VALIDATION OF NON-INVASIVE TRANSCUTANEOUS METHOD FOR GLOMERULAR FILTRATION RATE (GFR) IN OBESE MICE
Thomas Mullins
GLYCOGEN IN THE DIABETIC KIDNEY: THE HERO OR THE VILLAIN?
Mitchell Sullivan
AN AUDIT OF COMPLIANCE WITH PRESCRIBED DIALYSIS HOURS IN A HOME HEMODIALYSIS POPULATION
William Middleton
SUBCLINICAL ACUTE KIDNEY INJURY (sAKI) MODIFIES BIOMARKER PROFILES IN SUBCLINICAL CHRONIC KIDNEY DISEASE (sCKD)
Lena Succar
KIDNEY FUNCTION, GLUCOSE-LOWERING TREATMENT AND HBA1C LEVELS IN PEOPLE WITH PREVALENT DIABETES: A POPULATION-BASED COHORT STUDY (EXTEND45)
Celine Foote
C3 NEPHROPATHY AND MESANGIOCAPILLARY GLOMERULONEPHRITIS –  NEW DEVELOPMENTS IN UNDERSTANDING THE PATHOGENESIS
Tom Barbour


Dr Tom Barbour graduated in Medicine in 2004 at the University of Sydney, where he had previously obtained an Arts degree with honours in classical languages.  He was a specialist trainee in nephrology at Royal Melbourne Hospital and at the Churchill Hospital, Oxford, UK, and received his Fellowship of the Royal Australasian College of Physicians in 2012. Full biography.

RESIDUAL RENAL FUNCTION IN NOCTURNAL VS CONVENTIONAL HAEMODIALYSIS PATIENTS: A PROSPECTIVE OBSERVATIONAL STUDY
Lee Skeat
PAR-2 DOES NOT CONTRIBUTE TO TUBULAR DAMAGE OR RENAL FIBROSIS IN THE OBSTRUCTED KIDNEY
David Nikolic-Paterson
THE HIGH INCIDENCE OF DIABETIC MYONECROSIS IN FAR NORTH QUEENSLAND, THE DIFFERENTIAL DIAGNOSIS WE MIGHT BE MISSING IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Robert Johnston, Jarrad Koppen
SOCIO-DEMOGRAPHIC CHARACTERISTICS, OUT OF POCKET EXPENDITURE AND GEOGRAPHICAL DISTANCE TRAVELLED FOR CARE OF HEMODIALYSIS PATIENTS IN INDIA
Sradha Kotwal
COMBINED PARICALCITOL AND ENALAPRIL IMPROVES HYPERTENSION BUT NOT KIDNEY CYST GROWTH IN EXPERIMENTAL POLYCYSTIC KIDNEY DISEASE
Priyanka Sagar
IMPACT OF E-HEALTH INTERVENTIONS TO IMPROVE CLINICAL AND PATIENT CARE IN CHRONIC KIDNEY DISEASE: A COCHRANE SYSTEMATIC REVIEW
Jessica Stevenson
WHAT ABOUT US? INDIGENOUS CHILDREN WITH A PARENT ON DIALYSIS – WHAT ARE THE OUTCOMES?
Gillian Gorham
THE ROLE OF CILIAL PROTEIN#1 IN DIABETIC KIDNEY DISEASE (DKD)
Sanela Redzepagic
[Presented by Chunlan Huang]
THE GREEN NEPHROLOGY ACTION TEAM [GNAT]: A VECTOR FOR CHANGE
John Agar
TO SHOW HOW BIOIMPEDANCE CARDIOGRAPHY (BIC) MIGHT HELP US TO PREDICT AND PREVENT INTRADIALYTIC HYPERTENSION AND HYPOTENSION
Fei Fei Pan
BLOCKADE OF RIPK3 MODIFIES RENAL FIBROGENESIS THROUGH INHIBITION OF NF ΚB
Ying Shi
DIALYSIS PLASTIC WASTE RECYCLED AS A CONCRETE INCORPORATIVE
John Agar
1000-1030 Morning Tea | Exhibition Area, Parkside Ballroom, Level 2
1005-1030 Annual Renal Scientist’s Meeting | MR C3.2, Level 3
1030-1230 Concurrent Session 4 | Level 3
Shaun Summers Clinical Trainee Prize Session  | Cockle Bay
Chairs: Germaine Wong & Wai Lim
Seminar 4: Basic Science | MR C3.2
Chairs: Greg Tesch & Yiping Wang
Mini Orals | MR C3.4+C3.5
Epidemiology & Public Health
Chairs: Kevan Polkinghorne & Jaquelyne Hughes
Mini Orals  | MR C3.6
Cardiovascular / Hypertension
Chairs: Tracey Ying & Matthew Roberts
PERSONALISED IMMUNOLOGY IN THE MANAGEMENT OF COMPLEX AUTOIMMUNITY
Prianka Puri
THE ROLE OF cGMP AND ITS SIGNALING PATHWAYS IN KIDNEY DISEASE
Glenda Gobe


Associate Professor Glenda Gobe is a molecular biologist with a well-established international reputation in kidney disease research. She is a molecular biologist and pathologist who has published on research into renal atrophy and regeneration, fibrosis, inflammation, and kidney cancer. Full biography.

BACTRIM PROPHYLAXIS FOR MELIOIDOSIS IN PATIENTS RECEIVING HAEMODIALYSIS
Ken Chau, Katherine Kang
IMPACT OF DIETARY SODIUM REDUCTION ON ESTIMATED GLOMERULAR FILTRATION RATE IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Amy Kang
EFFECTIVENESS OF MULTIMODAL INTERVENTIONS IN IMPROVING ARTERIOVENOUS FISTULA (AVF) USE OF NEW PLANNED HAEMODIALYSIS PATIENTS – A SINGLE CENTRE STUDY
Pek Ghe Tan
LONG-CHAIN OMEGA-3 POLYUNSATURATED FATTY ACIDS AND PATIENT-LEVEL OUTCOMES IN CHRONIC KIDNEY DISEASE: META-ANALYSIS OF RANDOMISED TRIALS
Valeria Saglimbene
CARDIOVASCULAR MORTALITY RATES IN PEOPLE WITH END-STAGE KIDNEY DISEASE WITH PRE-EXISTING CARDIOVASCULAR DISEASE
Nicole De La Mata
CKD.QLD: ASSOCIALTION OF MONOCLONAL GAMMOPATHIES AND CHRONIC KIDNEY DISEASE
Sally Wilkinson
INFECTION-RELATED HOSPITALISATIONS ACROSS DIFFERENT LEVELS OF KIDNEY FUNCTION: DATA FROM THE EXTEND45 STUDY
Brendon Neuen
CARDIOVASCULAR EVENTS INCREASE THE RISK OF MORTALITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Andrew Jeyaruban
THE ASSOCIATION OF BODY MASS INDEX CHANGE ONE YEAR POST KIDNEY TRANSPLANTATION WITH GRAFT AND PATIENT SURVIVAL: A COMPARATIVE STUDY BETWEEN INDIGENOUS AND NON-INDIGENOUS AUSTRALIANS
Priyanka Subramani
CKD PREVALENCE AMONG AUSTRALIAN ADULTS OVER TIME 1999–2000 AND 2011–12
Thao Vu
DOES THE TYPE OF INTERVENTION FOR ISCHAEMIC HEART DISEASE IMPACT ON MORTALITY AND MORBIDITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Andrew Jeyaruban
BALLOON ANGIOPLASTY WITH CLOT LYSIS AS A FIRST LINE MEASURE FOR SALVAGE OF THROMBOSED ARTERIO-VENOUS ACCESS (AVA)
Catherine Wilkinson
THERAPEUTIC TARGETING OF SIGNALING PATHWAYS IN ACUTE KIDNEY INJURY
David Nikolic-Paterson


David Nikolic-Paterson is an NHMRC Senior Research Fellow and is Head of Laboratory Research in the Department of Nephrology at Monash Medical Centre in Melbourne, and a Group Leader in the Monash University Centre for Inflammatory Diseases. Full biography.

GEOGRAPHICAL VARIATION IN CHRONIC KIDNEY DISEASE
Thao Vu
CARDIOVASCULAR EVENTS DO NOT ACCELERATE DECLINE OF RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Andrew Jeyaruban
POST KIDNEY TRANSPLANT NEUTROPAENIA IN SOUTHERN TASMANIA
Stephanie Kuo
PREDICTORS OF PROGRESSION OF CHRONIC KIDNEY (CKD) IN AUSTRALIAN GENERAL PRACTICE PATIENTS
Masuma Khanam
THE EFFECT OF SPIRONOLACTONE ON RENAL INJURY (FIBROSIS) IN A HYPERTENSIVE TRANSGENIC CYP1A1REN2 RAT MODEL.
Catherine Leader
KIDNEY TRANSPLANT AND RECIPIENT OUTCOMES IN HYPEROXALURIA
Vanessa Heron
INTERVENTIONS TO AID EMPLOYMENT FOR PEOPLE ON DIALYSIS
Nina Li
MEDICATION ADHERENCE IN ADULTS WITH ADVANCED CHRONIC KIDNEY DISEASE
Wubshet Tesfaye
A PILOT STUDY OF WEARABLE DEVICES TO DETECT SEPSIS
Jennifer Yo
RENAL BIOPSIES IN PATIENTS WITH DIABETES: CAN WE PREDICT PATHOLOGY? A SINGLE CENTRE STUDY FROM FAR NORTH QUEENSLAND
Lee Skeat
POTENTIALLY INAPPROPRIATE MEDICATION USE IN ADULTS WITH ADVANCED CHRONIC KIDNEY DISEASE
Wubshet Tesfaye
1135-1230 ANZDATA | Cockle Bay
Chairs: Matthew Jose & Stephen McDonald
MITOCHONDRIAL DYSFUNCTION AND ITS THERAPEUTIC TARGETING IN KIDNEY DISEASE
Josephine Forbes


Prof Forbes completed her PhD in Paediatric Nephrology in 2000 at the University of Melbourne and Royal Children’s Hospital in Melbourne, Australia. She then continued her training as a post-doctoral fellow in diabetes and kidney disease at both Austin Health and Baker IDI Heart and Diabetes Institute in Melbourne, Australia. Full biography.

EXAMINING LEGAL CAUSE OF DEATH IN NATIONAL REGISTRIES FOR PEOPLE WHO WITHDRAW FROM RENAL REPLACEMENT THERAPY: AN AUSTRALIAN AND NEW ZEALAND POPULATION-BASED COHORT STUDY
Victor Khou
HYPERTENSION AND DIABETES DIFFERENTIALLY AFFECT RENAL REACTIVE OXYGEN SPECIES AND CATECHOLAMINE CONTENT
Anna Watson
KUPI – DRINKING WATER AND RENAL DISEASE IN REMOTE AREAS OF AUSTRALIA
Christine Jeffries-Stokes
THE EFFECTS OF OMEGA-3 FATTY ACIDS ON INFLAMMATION, PRO-ATHEROGENIC CYTOKINES AND LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN CHRONIC KIDNEY DISEASE PATIENTS
Kenneth Yong
SOCIOECONOMIC, DEMOGRAPHIC AND CLINICAL ASSOCIATIONS OF CHRONIC KIDNEY DISEASE IN DIABETES IN A POPULATION-BASED NSW COHORT: RESULTS FROM THE EXTEND45 STUDY
Louisa Sukkar
PROFILING CARDIAC BIOMARKERS PREDICTS CARDIAC PATHOPHYSIOLOGY IN URAEMIC CARDIOMYOPATHY
Amy Crosthwaite
THE MAKE-UP OF CARDIOVASCULAR DISEASE AS KIDNEY FUNCTION DECLINES: RESULTS FROM A POPULATION-BASED COHORT STUDY (EXTEND45)
Louisa Sukkar
IMPROVING CARDIOVASCULAR OUTCOMES THROUGH PHOSPHATE LOWERING IN CKD? – BASELINE CHARACTERISTICS OF PARTICIPANTS IN THE ‘IMPACT OF PHOSPHATE REDUCTION ON VASCULAR END-POINTS IN CHRONIC KIDNEY DISEASE’ (IMPROVE-CKD) STUDY
Nicole Lioufas
PREDICTORS OF CHRONIC KIDNEY DISEASE IN THE EXTEND45 STUDY: A NSW POPULATION-BASED STUDY
Amy Kang
IMPACT OF TYPE 2 DIABETES MELLITUS (T2DM), WITH OR WITHOUT DIABETIC NEPHROPATHY, ON CARDIOVASCULAR DISEASE (CVD) AND ALL CAUSE MORTALITY IN END-STAGE KIDNEY DISEASE PATIENTS: A POPULATION COHORT STUDY
Wai Lim
1230-1330 Lunch | Exhibition Area, Parkside Ballroom, Level 2
1230-1330 CREED AGM | Business Suite 2.1 , Level 2
1240-1320 PKD Symposia – Polycystic Kidney Disease: from the basic science to therapeutic outcomes | MR C3.4+C3.5, Level 3
 1330-1500 Concurrent Session 5 | Level 3
Basic Science Award | Cockle Bay
Chairs: Jacqueline Phillips & Veena Roberts
Mini Orals | MR C3.2
Pregnancy Associated / Genetics
Chairs: Amali Mallawaarachchi & Carolyn Van Eps
Mini Orals | MR C3.4+C3.5
Health Services Research
Chairs: Martin Howell & Helen Healy
Mini Orals | MR C3.6
Transplantation
Chairs: Ross Francis & Karen Keung
THE ENDOTHELIAL GLYCOCALYX IS DAMAGED WITH WORSENING KIDNEY DISEASE AND CORRELATES WITH MARKERS OF ENDOTHELIAL DYSFUNCTION
Hui Liew
SAFETY OF RENIN-ANGIOTENSIN SYSTEM BLOCKERS IN EARLY PREGNANCY: A POPULATION-BASED STUDY
Sean Kennedy
FACTORS THAT INFLUENCE HOSPITALISATIONS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Andrew Jeyaruban
ACUTE REJECTION AND ALLOGRAFT OUTCOMES IN INDIGENOUS AND NON-INDIGENOUS TRANSPLANT RECIPIENTS: THE WESTERN AUSTRALIAN EXPERIENCE
Prue Howson
IDENTIFYING BABIES BORN TO MOTHERS RECEIVING RENAL REPLACEMENT THERAPY IN SOUTH AUSTRALIA (SA) 1991-2013: AN ANZDATA AND PERINATAL DATA LINKAGE STUDY
Shilpa Jesudason
OVERCOMING BARRIERS FOR INDIGENOUS AUSTRALIANS GAINING ACCESS TO THE KIDNEY TRANSPLANT LIST
Amy Atkinson
[withdrawn mini oral}
NADPH-OXIDASE NOX5 AGGRAVATES RENAL INJURY IN THE AKITA MOUSE MODEL OF DIABETIC NEPHROPATHY
Karin Jandeleit-dahm
SIRT1 ATTENUATES KIDNEY DISORDERS IN OFFSPRING DUE TO MATERNAL HIGH-FAT FEEDING
Long Nguyen
CHARACTERISTICS, MORTALITY AND RENAL OUTCOMES OF ATSI PATIENTS WITH DIABETES AND CKD WHO RECEIVE SPECIALIST NEPHROLOGY CARE
Ken-Soon Tan
OUTCOME MEASURES FOR LIFE PARTICIPATION IN PATIENTS WITH KIDNEY TRANSPLANTATION
Martin Howell
EFFECT OF PREVENTATIVE LOW-DOSE ASPIRIN TREATMENT ON EXPERIMENTAL PREECLAMPSIA INDUCED BY TNF-α IN PREGNANT MICE
Katrina Chau
[presenter not able to attend] ESTABLISHING A CORE OUTCOME MEASURE FOR LIFE PARTICIPATION: A STANDARDISED OUTCOMES IN NEPHROLOGY – KIDNEY TRANSPLANTATION (SONG-TX) CONSENSUS WORKSHOP REPORT
Karine Manera
TARGETING CD103+ DENDRITIC CELLS USING FLT3 INHIBITORS FOR TREATMENT OF KIDNEY DISEASE; RELEVANCE TO HUMAN KIDNEY DISEASE
Titi Chen
MITOCHONDRIAL ANTIOXIDANT PREVENTS METABOLIC AND RENAL DYSFUNCTION INDUCED BY MATERNAL SMOKING
Gerard Li
ECONOMIC ANALYSIS OF REGULAR HEMODIALYSIS TREATMENT IN END-STAGE KIDNEY DISEASE
Made Rama Putra
INTERVENTIONS FOR NON-MELANOMA SKIN CANCERS IN RECIPIENTS OF A SOLID-ORGAN TRANSPLANT: A META-ANALYSIS OF RANDOMISED TRIALS
Edmund Chung
A COHORT STUDY UTILISING BIOCHEMICAL ASSESSMENT OF ASPIRIN RESISTANCE VS NON-COMPLIANCE IN HIGH-RISK PREGNANT WOMEN
Renuka Shanmugalingam
SETTING UP A METABOLIC KIDNEY STONE ASSESSMENT CLINIC – THE AUCKLAND CITY HOSPITAL EXPERIENCE
Elizabeth Curry
TRANSCRIPTOMICS ASSOCIATION WITH ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION: INTEGRATED ANALYSIS OF GENE EXPRESSION-BASED MICROARRAY DATA
Yue Cao
CYCLOPHILIN INHIBITION ATTENUATES RENAL FIBROSIS IN THE OBSTRUCTED KIDNEY
Khai Gene Leong
INCREASED EXPRESSION OF 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE ISOFORMS IN URINARY EXOSOMES IN PRE-ECLAMPSIA
Rachael Ellis
CHRONIC KIDNEY DISEASE: WHO ARE THE HIGH COST USERS OF HOSPITAL CARE?
Marcin Sowa
PHYSICAL AND PSYCHOLOGICAL SYMPTOM BURDEN OF RENAL TRANSPLANT AND DIALYSIS PATIENTS
Jeffrey Ha
MICROALBUMINURIA AS AN EARLY PREDICTOR OF PREECLAMPSIA IN THE PRE-GESTATIONAL DIABETIC POPULATION
Monica Zen
ASSESSING THE RISK AND SEVERITY OF HOSPITALISATIONS ACCORDING TO LEVEL OF KIDNEY FUNCTION: AN EXTEND45 ANALYSIS
Min Jun
UNDERSTANDING IMMUNOSUPPRESSANT USE IN KIDNEY TRANSPLANTATION: MAJOR CHANGES IN DRUG REGIMEN, SHIFTS IN DOSING OVER TIME, AND KAPLAN-MEIER SURVIVAL ESTIMATES BY MAJOR ERA USING THE ANZDATA REGISTRY
David Metz
VALIDATION OF HOUSEKEEPER GENES FOR NORMALISATION FOR RT-qPCR GENE EXPRESSION STUDIES IN ISCHAEMIC AND TOXICOLOGICAL CONDITIONS IN RAT MODELS
Sanjeeva Herath
ROLE OF CYCLIN-DEPENDENT KINASE 2 ON THE PROGRESSION OF JUVENILE CYSTIC KIDNEY DISEASE MICE
Jennifer Zhang
EVALUATING AND OPTIMISING THE DELIVERY OF KIDNEY SUPPORTIVE CARE
Louise Purtell
PRELIMINARY RESULTS OF THE ADOPT TRIAL: TOTAL AND UNBOUND MYCOPHENOLIC ACID CONCENTRATION CHANGES BEFORE AND AFTER KIDNEY TRANSPLANTATION
David Metz
DIETARY SODIUM INTAKE IS CORRELATED WITH SERUM COPEPTIN IN EARLY-STAGE AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Jennifer Zhang
PREDICTING IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN PEOPLE RECEIVING DIALYSIS: THE LEOPARD STUDY
Louise Purtell
MARKERS OF THE ENDOTHELIAL GLYCOCALYX AND ENDOTHELIAL DYSFUNCTION ARE IMPROVED AFTER RENAL TRANSPLANTATION
Hui Liew
RARE VARIANTS IN BLK CONTRIBUTE TO THE PATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS
Simon Jiang
RELATIONSHIP BETWEEN DNA DAMAGE AND KIDNEY CYST FORMATION IN MURINE AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Jennifer Zhang
YOUNGER ADULTS ALSO REQUIRE KIDNEY SUPPORTIVE CARE
Louise Purtell
1500-1530 Afternoon Tea | Exhibition Area, Parkside Ballroom, Level 2
1530-1730 Concurrent Session 6 | Level 3
1530-1600 Gender Equity | Cockle Bay
Chairs: Kate Wyburn & Angela Webster
Mini Orals | MR C3.2
Haemodialysis – Vascular Access & CKD-MBD/Anaemia/Adequacy
Chairs: Caroline Milton & Peter Kerr
Mini Orals | MR C3.4+C3.5
Paediatrics / Genetics
Chairs: Peter Trnka & Chanel Prestidge
Mini Orals | MR C3.6
General Nephrology / Interventional Nephrology
Chairs: Rob MacGinley & Gillian Gorham

GENDER EQUITY AND DIVERSITY IN THE ANZSN


Kate Wyburn is a full time Senior Staff Specialist Nephrologist and Director of Kidney Transplantation at The Royal Prince Alfred Hospital Sydney, the current Chair of the NSW Transplant Advisory Committee and member of the National Renal Transplant Advisory Committee.


Angela Webster is a Nephrologist and Transplant Physician, having trained in England, Scotland and Australia. She studied Clinical Epidemiology at the University of Sydney, and was awarded a PhD for her thesis Immunosuppression and malignancy in End Stage Kidney Disease in 2006.

CARDIOPULMONARY RECIRCULATION: AN UNDERRECOGNIZED CONTRIBUTOR TO HAEMODIALYSIS EFFECTIVENESS
Taren Bettler, Lukas Kairaitis
PREDICTORS OF CHRONIC KIDNEY DISEASE PROGRESSION DURING LATE ADOLESCENCE
Heeral Thakkar
IDENTIFYING PRINCIPLES AND STRATEGIES FOR INVOLVING PATIENTS AND CAREGIVERS IN RESEARCH IN CHRONIC KIDNEY DISEASE: A REPORT OF THREE WORKSHOPS
Talia Gutman
ARTERIO-VENOUS FISTULA OUTCOMES AND PREDICTORS OF PRIMARY FAILURE IN PATIENT CENTRED VASCULAR ACCESS MODEL
Fortune Ngwenya
LONG-TERM GLOMERULAR CAPILLARY GROWTH IN LAMBS FOLLOWING PRETERM BIRTH AND POSTNATAL VENTILATION
Fan Jiang
IDENTIFYING AND INTEGRATING PATIENT AND CAREGIVER PERSPECTIVES IN CLINICAL PRACTICE GUIDELINES FOR PERCUTANEOUS RENAL BIOPSY
Talia Gutman
DISTANCE TO A RURAL RENAL SERVICE AND INITIAL ACCESS IN HAEMODIALYSIS
Tamara Young
RENAL BIOPSY ADEQUACY AND COMPLICATIONS IN CHILDREN
Chen Cui
THE IMPACT OF MATERNAL ENVIRONMENT ON POLYCYSTIC KIDNEY DISEASE
Jacqueline Phillips
A SURVEY OF DIALYSIS CATHETER MANAGEMENT PRACTICES IN AUSTRALIAN AND NEW ZEALAND
Brendan Smyth
QUANTIFICATION OF MENDELIAN GENETIC DISEASE IN THE PAEDIATRIC RENAL CLINIC
Yadhavan Upendran
THE EVALUATION OF INDIVIDUALISED TELEHEALTH INTENSIVE COACHING TO PROMOTE HEALTHY EATING AND LIFESTYLE IN CHRONIC KIDNEY DISEASE (ENTICE-CKD): A PILOT RANDOMISED CONTROLLED TRIAL
Jaimon Kelly
 1600-1730 GNAT (Green Nephrology Action Team)
Chair: Bruce Cooper & Meg Jardine
REASONS FOR DIALYSIS CATHETER INSERTION – REAL TIME PROSPECTIVE DATA FROM THE REDUCCTION PROJECT
Sradha Kotwal
PROGNOSTIC INDICATORS OF RENAL OUTCOMES IN BOYS WITH POSTERIOR URETHRAL VALVES
Sarah Keenan
RENAL SUPPORTIVE CARE PROGRAMS IMPROVE PATIENT SURVIVAL AND REDUCE HOSPITALISATIONS: AN OBSERVATIONAL COHORT STUDY
Xiu Xian Chia
IMPLICATIONS OF CLIMATE CHANGE FOR NEPHROLOGY
Katherine BarracloughKatherine is a Consultant Nephrologist at the Royal Melbourne Hospital. She completed her basic medical training in Melbourne then undertook advanced training in Nephrology in Vancouver, Canada, New Delhi India and Brisbane, Australia


PROGRESS TOWARDS ENVIRONMENTALLY SUSTAINABLE RENAL CARE
John Agar

John has been a Clinical Nephrologist at the University Hospital Geelong, Barwon Health, Geelong since 1978 and is a Conjoint Professor of Medicine at Deakin University School of Medicine and Barwon Health, Geelong.


ENVIRONMENTAL WINS FROM THE AFFORDABLE DIALYSIS PRIZE
John Knight

John Knight is a part time professorial fellow in the renal and metabolic division of The George Institute for Global Health, where his academic research explores the clinical and economic outcomes of dialysis in resource constrained environments.

EFFECTS OF FISH OIL SUPPLEMENTATION AND ASPIRIN USE ON THE NEED FOR ARTERIOVENOUS FISTULA INTERVENTIONS AND CENTRAL VENOUS CATHETERS IN PATIENTS REQUIRING HAEMODIALYSIS
Andrea Viecelli
THE URINARY PROTEOME OF PRETERM NEONATES: ASSOCIATIONS WITH GESTATIONAL AGE AND RENAL FUNCTION
Megan Sutherland
ASSESSING THE IMPACT OF HYPERURICAEMIA, GOUT AND ALLOPURINOL TREATMENT ON PROGRESSION OF RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Andrew Jeyaruban
ASSOCIATION OF BRAIN NATRIURETIC PEPTIDE (BNP) WITH KIDNEY FUNCTION DECLINE AND RISK OF LONG-TERM CHRONIC KIDNEY DISEASE (CKD)-RELATED OUTCOMES IN ELDERLY WOMEN
Anoushka Krishnan
VALIDATION OF A SCORED SALT QUESTIONNAIRE TO SCREEN FOR HIGH DIETARY SALT INTAKE IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Annette Wong
RENAL CELL CARCINOMA PROGRESSION IS ENHANCED BY LYMPH NODE STROMAL CELL REGULATION OF CANCER CELL PROTEIN EXPRESSION
Glenda Gobe
LONGITUDINAL CHANGES IN BONE AND MINERAL METABOLISM AFTER CESSATION OF CINACALCET IN DIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
Irene Ruderman
RAPID TRANSLATION OF NOVEL NEPHROGENETIC AETIOLOGIES FROM FIRST REPORT TO ACCREDITED DIAGNOSTIC OUTCOME
Andrew Mallett
DIETARY RESISTANT STARCH PROTECTS AGAINST DIABETIC NEPHROPATHY BY INHIBITION OF COMPLEMENT
Matthew Snelson
CLINICAL OUTCOMES OF HOME HAEMODIALYSIS WITH LOW DIALYSATE VOLUME
Sunita Nair
CHRONIC KIDNEY DISEASE PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE OR OTHER INHERITABLE KIDNEY DISEASE HAVE DISTINCT CHARACTERISTICS AND HIGHER ASSOCIATED HEALTHCARE COSTS
Andrew Mallett
SURGEON VERSUS NEPHROLOGIST-INSERTED PERITONEAL DIALYSIS CATHETERS: EXPERIENCES FROM A METROPOLITAN CENTRE IN SYDNEY
Nasir Shah
FIBROBLAST GROWTH FACTOR 23 AS PREDICTOR OF ABDOMINAL AORTIC CALCIFICATION IN CHRONIC KIDNEY DISEASE PATIENTS WITH REGULAR HEMODIALYSIS: A SINGLE CENTER STUDY
Riri Andri Muzasti
CHILD AND PARENTAL PERSPECTIVES ON COMMUNICATION AND DECISION-MAKING IN PAEDIATRIC CHRONIC KIDNEY DISEASE: A FOCUS GROUP STUDY
Talia Gutman
AN AUDIT OF POST-RENAL BIOPSY COMPLICATION RATE AND DIAGNOSTIC YIELD OF ALLOGRAFT AND NATIVE KIDNEYS
Asrar Khan
1730 Sessions Close
1900 till late ANZSN ASM Dinner | Jones Bay Wharf
Join other ASM delegates in celebrating what we know will be another fantastic ANZSN Gala Dinner.  In addition to the President’s address and award presentations the dinner will include a 3 course meal with drinks and entertainment.


The ASM Gala Dinner venue, Jones Bay Wharf, is located 14 minutes walk along Darling Harbour.  We anticipate most guests will enjoy this walk, however if you have mobility issues (or if foot wear is not conducive to walking) there will be coaches available for the transfer.  Please indicate during registration if you would like to catch the coach to the dinner instead of walking, this coach will depart at 1845.  Coaches will depart and return to the ICC with drop offs to some accommodation venues on the return trip only.  Coaches will be available for ALL GUESTS for the RETURN TRIP.  They will depart on a staggered timetable from the conclusion of dessert to the end of the dinner.


Wednesday 12th September 2018 – ANZSN ASM

0730-0800 BEST-Fluids Trial  (bookings essential – click here) , E5.6, Level 5
0800 Registration Desk Open & Speakers Preparation Room Open | Ground Level
  Plenary 3 | Cockle Bay, Level 3
Chair: Chen Au Peh
0830-0930 Keynote Speaker: David Jayne
RECENT INSIGHTS ON ANCA ASSOCIATED VASCULITIS: PATHOGENESIS, CLINICAL TRIALS AND THERAPEUTICS (PEXIVAS UPDATE)


David Jayne is Professor of Clinical Autoimmunity at the School of Clinical Medicine, University of Cambridge, UK. His research group conducts clinical trials and biomarker studies in vasculitis and lupus. He is the Director of the Vasculitis and Lupus Clinic and President of the European Vasculitis Society. Full biography.

Jacquot Award Past Awardee Presentations
Chair: Toby Coates & Natasha Rogers
0930-1030

Speaker 1: Jaquelyne Hughes, NHMRC Early Career Research Fellow & Nephrologist, Royal Darwin Hospital

Dr Jaquelyne Hughes works as a nephrologist at Royal Darwin Hospital and NHMRC early career research fellow at Menzies School of Health Research. She is a Torres Strait Islander woman who grew up in Darwin before studying medicine at Newcastle University. Full biography.

 


Speaker 2: Darren Roberts, Staff Specialist, St Vincent’s Hospital, Sydney

Darren Roberts completed physician training in Canberra and Sydney in both nephrology and clinical pharmacology. Full biography.

1030-1100 Morning Tea | Exhibition Area, Parkside Ballroom, Level 2
 1100-1230 Concurrent Session 7 | Level 3
Seminar 5: Basic Science | Cockle Bay
Chair: David Nikolic-Paterson & Jacqueline Phillips
Mini Orals | MR C3.2
Genetics
Chairs: Vincent Lee & Fiona Mackie
Mini Orals | MR C3.4
Transplantation
Chairs: Siah Kim & Kenneth Yong
Mini Orals | MR C3.5
Acute Kidney Injury
Chairs: Shaundeep Sen & Martin Gallagher
RECLASSIFYING TRANSPLANT INJURY
Minnie Sarwal


Minnie Sarwal is Professor of Surgery, with joint appointments in Medicine and Pediatrics, Director of Precision Transplant Medicine at the University of California San Francisco (UCSF), and additional positions as Adjunct Professor, Haas School of Business, University of California Berkeley, and Adjunct Professor at the Faculty of Health Sciences, Odense, Sweeden.  Full biography.

PROPKD SCORE PREDICTS KIDNEY DECLINE IN CLINICAL PRACTICE AMONGST AUSTRALIAN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Samuel Chan
MORTALITY IN LIVING KIDNEY DONORS: AN AUSTRALIAN AND NEW ZEALAND COHORT STUDY USING DATA LINKAGE
Angela Webster
TRANSCUTANEOUS MEASUREMENT OF GFR BETTER REFLECTS CHANGES IN RENAL FUNCTION FOLLOWING INJURY
Kylie Taylor
ADULT-DIAGNOSED NON-SYNDROMIC NEPHRONOPHTHISIS IN AUSTRALIAN FAMILIES CAUSED BY BIALLELIC NPHP4 VARIANTS
Rebecca Hudson
KIDNEY GRAFT SURVIVAL AND PATIENT SURVIVAL IN TYPE 1 DIABETICS AFTER KIDNEY TRANSPLANT ALONE COMPARED TO SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT
James Hedley
ACUTE KIDNEY INJURY IN SURGICAL PATIENTS IN AN OUTER-METROPOLITAN HOSPITAL
Benignus Logan
HEREDITARY LEIOMOYOMATOSIS AND RENAL CELL CARCINOMA SYNDROME (HRLCC): AN EFFECTIVE MULTIDISCIPLINARY APPROACH TO A HEREDITARY RENAL CANCER PREDISPOSING SYNDROME
Mohammad Al-Shinnag
ACCOUNTING FOR BIAS WHEN A RANDOMIZED CONTROLLED TRIAL IS NOT POSSIBLE: COMPARING KIDNEY TRANSPLANTATION WITH DIALYSIS SURVIVAL IN INDIGENOUS PATIENTS.
Paul Lawton
SERUM AND URINARY MICRORNAS AS BIOMARKERS FOR ACUTE KIDNEY INJURY FOLLOWING POISONING WITH POTASSIUM PERMANGANATE AND OXALIC ACID
Fathima Shihana Haniffa Salahudeen
BIRT HOGG DUBÉ SYNDROME (BHD): AN EFFECTIVE MULTIDISCIPLINARY APPROACH TO A HEREDITARY RENAL CANCER PREDISPOSING SYNDROME
Mohammad Al-Shinnag
INFECTION-RELATED MORTALITY FOLLOWING KIDNEY TRANSPLANTATION IN AUSTRALIA AND NEW ZEALAND
Samuel Chan
THE EFFECT OF CORTICOSTEROIDS IN THE TREATMENT OF DRUG-INDUCED ACUTE INTERSTITIAL NEPHRITIS: A SYSTEMATIC REVIEW
Lena Quinto
GENETIC RENAL DISEASE IN TASMANIA
Gabrielle Brailsford
A DESCRIPTIVE REVIEW OF RENAL TRANSPLANT OUTCOMES IN RECIPIENTS ≥ 70 YEARS OLD FROM 2000 TO 2015
Brian Doucet
A20 REGULATION OF INFLAMMATION IN A MOUSE MODEL OF ISCHEMIC ACUTE KIDNEY INJURY
Danny Nguyen-Ngo
IMPLEMENTING GENOMICS INTO NEPHROLOGY SERVICES- A REVIEW OF THE LITERATURE AND STUDY PROTOCOL
Kushani Jayasinghe
ABDOMINAL AORTIC CALCIFICATION PREDICTS CARDIOVASCULAR EVENTS AND MORTALITY IN KIDNEY AND SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT RECIPIENTS
Grahame Elder
ACUTE KIDNEY INJURY IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN PUBLIC NEPHROLOGY PRACTICES IN QUEENSLAND
Jianzhen Zhang
MICROBIOME IN CKD
Emad El-Omar


Professor El-Omar graduated in Medicine from Glasgow University, Scotland, and trained as a gastroenterologist. He worked as a Visiting Scholar/Scientist at Vanderbilt University, TN, and National Cancer Institute, MD, USA, and was Professor of Gastroenterology at Aberdeen University, Scotland, for 16 years before taking up the Chair of Medicine at St George & Sutherland Clinical School, University of New South Wales, Sydney, Australia. Full biography.

RANDOM DAYTIME SPOT URINE CORRELATES WITH TWENTY-FOUR HOUR URINE OSMOLALITY IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Carly Mannix
PERITONEAL REGULATORY MACROPHAGES PROLONG ALLOGRAFT SURVIVAL IN ISLET TRANSPLANTATION
Qi Cao
SIGNIFICANT IMPROVEMENT IN RENAL FUNCTION IN NEWLY DIAGNOSED MULTIPLE MYELOMA
Anthony Saponara
SEASONAL CHANGES IN FLUID INTAKE IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Carly Mannix
ONE YEAR SURVIVAL PROGNOSTIC FACTORS OF KIDNEY TRANSPLANT RECIPIENT AT DR KARIADI GENERAL HOSPITAL, INDONESIA: SIX YEAR EXPERIENCE
Mamang Bagiansah
DIAGNOSIS AND REFERRAL TO NEPHROLOGY SERVICES OF INPATIENTS WITH ACUTE KIDNEY INJURY
Zena Barakat
BEDSIDE TEST FOR DEFICIENT PERIPHERAL WARMTH PERCEPTION: A COMMON AND EARLY SIGN IN FABRY DISEASE
Blaze Nedanovski
OUTCOMES OF INTENSIVE CARE PATIENTS WITH ACUTE KIDNEY INJURY REQUIRING RENAL REPLACEMENT THERAPY
Krishna Karpe
AUSTRALIAN RENAL GENE PANELS (ARGP): RESULTS FROM FOUR YEARS OF TESTING
Hugh McCarthy
ACTIVATED CD47 PROMOTES ACUTE KIDNEY INJURY BY LIMITING AUTOPHAGY
Natasha Rogers
1230-1330

Lunch | Exhibition Area, Parkside Ballroom, Level 2


EXHIBITION HALL CLOSES 1330

1230-1330 World Congress Local Organising Committee Meeting | MR C3.4, Level 3 
  Plenary 4: Patient Perspectives | Cockle Bay, Level 3
Chairs: Allison Tong & Gopala Rangan
1330-1430

INDIGENOUS PATIENT VOICES SYMPOSIUM, DARWIN

Dr Jaquelyne Hughes works as a nephrologist at Royal Darwin Hospital and NHMRC early career research fellow at Menzies School of Health Research. She is a Torres Strait Islander woman who grew up in Darwin before studying medicine at Newcastle University. Full biography.


STRATEGIES FOR INVOLVING PATIENTS IN RESEARCH

Talia Gutman is a Research Officer and PhD candidate at the Sydney School of Public Health, The University of Sydney, Australia. Her primary research interest is in the area of patient and caregiver involvement in research in chronic kidney disease. Full biography.


EMPOWERING THE PATIENT VOICE FOR HIGH IMPACT RESEARCH

Nicki Scholes-Robertson is a clinical Physiotherapist who received a live donor transplant in November 2014. Nicki established in 2013 a Renal support group in her town Armidale NSW which continues to meet monthly. Full biography.

1430-1700 ANZPNA AGM | MR C3.4, Level 3
1430-1600

Patient Workshop (bookings essential) | MR C3.2, Level 3

  Plenary 5: Global Kidney Health | Cockle Bay, Level 3
Chair & Moderator: Carol Pollock
1430-1500 THE GLOBAL KIDNEY HEALTH ATLAS  –  THE CURRENT CLINICAL PERSPECTIVE
David Johnson


David Johnson is currently Director of the Metro South and Ipswich Nephrology and Transplant Service (MINTS) and Medical Director of the Queensland Renal Transplant Service at Princess Alexandra Hospital, Brisbane, Australia, Professor of Medicine and Professor of Population Health at University of Queensland, and Director of the Centre for Kidney Disease Research, Brisbane, Australia.  Full biography.

1500-1530 GLOBAL STRATEGIES TO REDUCE THE CLINICAL BURDEN OF KIDNEY DISEASE
Vlado Perkovic


Vlado Perkovic is Executive Director of The George Institute, Australia, Professor of Medicine at UNSW Sydney, and a Staff Specialist in Nephrology at the Royal North Shore Hospital. Full biography.

1530-1600 Moderated Panel Discussion
Alan Cass, Rob Walker, Karen Dwyer


Prof Walker is the senior academic nephrologist in New Zealand with extensive experience in the areas of clinical and experimental nephrology research with a particular emphasis on cardiovascular risk factors in chronic kidney disease and hypertension. He is the director of ‘The Kidney in Health and Disease’ Research group based at the University of Otago. Full biography.

 

1600 Official closing of the ASM
1600-1630

Farewell Afternoon Tea | Cockle Bay Foyer, Level 3


Thank you for another fantastic ASM.  Please join the committee and council for a farewell afternoon tea in the Cockle Bay Foyer overlooking the iconic Sydney Harbour.

  Australian and New Zealand Society of Interventional Nephrology (ANZSIN) Meeting 
Wednesday 12 to Friday 14 September 2018
Click here for more information

About ANZSN

The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the Annual Scientific Meeting

© 2015 - 2016 Conference Design Pty Ltd